awesome-med-research-skills/Academic Writing/lay-summary-for-cross-disciplinary-teams/SKILL.md
Rewrites technical research content into a structured lay summary that cross-disciplinary teams can quickly understand and act on. Use when the user wants to explain research to colleagues outside their specialty — clinicians, wet-lab scientists, bioinformaticians, product managers, or leadership. Trigger on: "lay summary", "explain my research to the team", "non-technical summary", "cross-disciplinary summary", "translate my findings", "align our team on the study", or any request to communicate research goals, findings, or next steps to a mixed or non-specialist audience. Part of the AIPOCH Academic Writing skill hub. Sits midstream: after research content is clarified, before downstream deliverables like slide decks or graphical abstracts.
npx skillsauth add aipoch/medical-research-skills lay-summary-for-cross-disciplinary-teamsInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Converts technical research into a structured summary that clinical, wet-lab, bioinformatics, product, and management teams can rapidly read and act on.
This skill sits midstream:
If the user's research content is still vague or unstructured, prompt them to clarify objectives and key findings first. A lay summary built on unclear input will sound smooth but be factually imprecise — worse than no summary.
Ask the user to provide any of:
Also ask: Who is the primary audience?
mixed (default) — all teams listedclinical — clinicians, medical staffwet-lab — bench scientists, experimentalistsbioinformatics — computational scientists, data analystsproduct — product managers, translational teamsmanagement — leadership, funders, executivesIf unspecified, use mixed and include all relevant audience bullets.
Before writing, internally map the input to these five elements:
| Element | What to find | |---|---| | Study goal | Why was this done? What problem does it address? | | System / population | What was studied? (patients, cells, datasets, samples…) | | Main finding | What did the data show? Be specific — avoid vague positives. | | Evidence boundary | What can this support? What remains uncertain or untested? | | Next action | What should each team know or do because of this? |
If any element is missing from the input, note it in the output and invite the user to fill in the gap.
Use the output template in assets/output-template.md.
Writing principles:
For audience-specific language guidance, read references/audience-guide.md.
Before delivering output, verify:
If a check fails, revise before presenting.
assets/output-template.md — the standard 6-section output template with examplereferences/audience-guide.md — language and framing guidance per audience typetools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.